Recent genetic advances in ADHD and diagnostic and therapeutic prospects

References

• Mannuzza S, Klein RG, Klein DF, Bessler A, Shrout P Accuracy of adult recall of childhood attention deficit hyperactivity disorder. A117. I PTchiatry159(11), 1882–1888 (2002).
   Google Scholar
• Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank and psychiatric status. Arch. Gen. Psychiatry 50(7), 565–576 (1993).
   Google Scholar
• Nada-Raja S, Langley JD, McGee R, Williams SM, Begg DJ, Reeder AT. Inattentive and hyperactive behaviors and driving offenses in adolescence. J. Am. Acad. Child Adolesc. fiychiatry36(4), 515–522 (1997).
   Google Scholar
• Thapar A, Holmes J, Poulton K, Harrington R. Genetic basis of attention deficit and hyperactivity. BE J. Psychiatry 174,105–111 (1999).
   PubMed Web of Science ®Google Scholar
• Levy F, Hay DA, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder, a category or a continuum? Genetic analysis of a large-scale twin study. Am. Acad. Child Adolesc. Psychiatry 36(6), 737–744 (1997).
   Google Scholar
• Faraone SV, Biederman J. Neurobiology of attention deficit hyperactivity disorder. PTchiatry44(10), 951–958 (1998).
   PubMed Web of Science ®Google Scholar
• Kirley A, Hawi Z, Daly G etal. Dopaminergic system genes in ADHD, toward a biological hypothesis. Neumpsychopharmacology27 (4), 607–619 (2002). An important attempt to combine the available data at the molecular level with pharmacological and animal models to formulate a biological hypothesis for attention deficit hyperactivity disorder.
   Google Scholar
• Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283(5400), 397–401 (1999).
   PubMed Web of Science ®Google Scholar
• Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder, a review and integration. Behav. Brain Res. 94(1), 127–152 (1998).
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu F, Gainetdinov P, Caron M. Genetic approaches to studying norepinephrin function, knockout of mouse norepinephrin transporter. Gene. Biol. PTchiatry 46, 1124–1130 (1999).
   PubMed Web of Science ®Google Scholar
• Aston-Jones G, Rajkowski J, Cohen J. Role of locus coeruleus in attention and behavioural flexibility. Biol. Psychiatry46, 1309–1320 (1999).
   Google Scholar
• Vallone D, Picetti R, Borrelli E. Structure and function of dopamine receptors. Neumsci. Biobehav. Rev 24(1), 125–132 (2000).
   Google Scholar
• Wong AH, Buckle CE, Van Tol HH. Polymorphisms in dopamine receptors,what do they tell us? Eur. j Pharmacol 410(2–3), 183–203 (2000). Useful review of the molecular structure and function of the dopaminergic system genes.
   Google Scholar
• Biederman J, Spencer T Attention-deficit hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol. Psychiatry 46(9), 1234–1242 (1999).
   PubMed Web of Science ®Google Scholar
• Amara S, Kuhar M. Neurotransmitter transporters, recent progress. Ann. Rev Neumsci. 16,73–93 (1993).
   PubMed Web of Science ®Google Scholar
• Giros B, Jaber M, Jones S, Wightman RM, Caron M. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379,606–612 (1996).
   Google Scholar
• Jaber M, Dumartin B, Sagne C et al. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur Neumsci. 11(10), 3499–3511 (1999).
   Google Scholar
• Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention deficit hyperactivity disorder — the spontaneously hypertensive rat. Brain Res. 676 (2), 343–351 (1995).
   Google Scholar
• Baumeister AA, Hawkins MF. Incoherence of neuroimmaging studies of attention deficit/hyperactivity disorder. Gun. Neumpharmacol 24,2–10 (2001).
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang GJ, Fowler JS et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry 155,1325–1331 (1998).
   PubMed Web of Science ®Google Scholar
• Seeman P, Madras BK. Antihyperactivity medication, methylphenidate and amphetamine. Mal Psychiatry 3,386–396 (1998).
   PubMed Web of Science ®Google Scholar
• Cook EH, Stein MA, Krasowski MD et al. Association of attention deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56,993–998 (1995).
   PubMed Web of Science ®Google Scholar
• Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mal PTchiatry2, 311–313 (1997).
   Google Scholar
• Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder, preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mal PTchiatry 4, 192–196 (1999).
   PubMed Web of Science ®Google Scholar
• Waldman ID, Rowe DC, Abramowitz A et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children, heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet. 63, 1767–1776 (1998).
   PubMed Web of Science ®Google Scholar
• Curran S, Mill J, Tahir E et al. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mal fiychiatry6(4), 425–428 (2001).
   Google Scholar
• Payton A, Holmes J, Barrett JH et al. Susceptibility genes for a trait measure of attention deficit hyperactivity disorder, a pilot study in a nonclinical sample of twins. Psychiatry Res. 31,105(3), 273–278 (2001).
   Google Scholar
• Chen CK, Chen SL, Mill J et al. The dopamine transporter gene is associated with attention deficithyperactivity disorder in a Taiwanese sample. Mal Psychiatry 8(4), 393–396 (2003).
   PubMed Web of Science ®Google Scholar
• Barr CL, Xu C, Kroft J et al. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention deficit hyperactivity disorder. Biol. Psychiatry 49(4), 333–339 (2001)
   PubMed Web of Science ®Google Scholar
• Asherson P, Virdee V, Curran S et al. Association study of DSM IV attention deficit hyperactivity disorder (ADHD) and monoamine pathway genes. Am. J. Med. Genet. 81,549 (1998).
   Web of Science ®Google Scholar
• Palmer CG, Bailey JN, Ramsey C et al No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. PTchiatr Genet. 9(3), 157–160 (1999).
   Google Scholar
• Holmes J, Payton A, Barrett JH et al Family-based and case control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mal Bychiatry5, 523–530 (2000).
   PubMed Web of Science ®Google Scholar
• Todd RD, Jong YJ, Lobos EA, Reich W, Heath AC, Neuman RJ. No association of the dopamine transporter gene 3 -VNTR polymorphism with ADHD subtypes in a population sample of twins. Am. J. Med. Genet. 105(8), 745–748 (2001).
   Google Scholar
• Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH. Attention deficit hyperactivity disorder, a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J. Med. Genet. 105(5), 471–478 (2001).
   Google Scholar
• Muglia P, Jain U, Inkster B, Kennedy JL. A quantitative trait locus analysis of the dopamine transporter gene in adults with ADHD. Neuropsychopharmacology 27 (4), 655–662 (2002).
   PubMed Web of Science ®Google Scholar
• Maher BS, Marazita ML, Ferrell RE, Vanyukov MM. Dopamine system genes and attention deficit hyperactivity disorder, a meta-analysis. Psychiatr Gene 2(4), 207–215 (2002).
   Google Scholar
• •Meta-analysis on all published data which further support the role of the dopaminergic system in predisposing attention deficit hyperactivity disorder.
   Google Scholar
• Swanson JM, Flodman P, Kennedy J et al. Dopamine genes and ADHD. Neurosci. Biobehav. Rev 24,21–22 (2000).
   PubMed Web of Science ®Google Scholar
• Heinz A, Goldman D, Jones DW et al Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology22(2), 133–139 (2000).
   PubMed Web of Science ®Google Scholar
• Krause KL, Dresel SH, Krause J, Kung HF, Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder, effects of methylphenidate as measured by single photon emission computed tomography. Neurosci. Lett. 285,107–110 (2000).
   Google Scholar
• Meador-Woodruff JH, Grandy DK, Van TollIf IM, Damask SP, Little KY.Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology10,239–248 (1994).
   Google Scholar
• Ashgari V, Sanyal S, Buchwaldt S. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J. Neurochem. 65,1157-1165 (1995).
   Google Scholar
• LaHoste GL, Swanson JM, Wigal SB et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mal PTchiatry 1, 121–124 (1996).
   PubMed Web of Science ®Google Scholar
• Swanson JM, Sunohara GA, Kennedy JL et al Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD), a family-based approach. Mal PTchiatry3,38–41 (1998).
   PubMed Web of Science ®Google Scholar
• Smalley SL, Bailey JN, Palmer CG et al. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit. Mal Psychiatry3, 427–430 (1998).
   PubMed Web of Science ®Google Scholar
• Rowe DC, Stever C, Giendinghagen LN et al Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mal Psychiatry3, 419–426 (1998).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Weiffenbach B et al Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Arn. PTchiatry 156 (5), 768–770 (1999) .
   Google Scholar
• Muglia P, Jain U, Macciardi F, Kennedy JL. Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am. J. Med. Genet 96,273–277 (2000).
   Google Scholar
• Sunohara GA, Roberts W, Malone M. Linkage of the dopamine D4 receptor gene and attention deficit hyperactivity disorder. AM. Acad. Child Adolesc. Psychiatry 39(12), 1537–1542 (2000).
   Google Scholar
• Tahir E, Yazgan Y, Cirakoglu B, Ozbay F, Waldman I, Asherson PJ. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mal Psychiatry 5 (4), 396–404 (2000) .
   Google Scholar
• Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MET. Attention-deficit hyperactivity disorder, a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am. J. Med. Genet. 105(5), 471–478 (2001).
   Google Scholar
• Holmes J, Payton A, Barrett J et al. Association of DRD4 in children with ADHD and comorbid conduct problems. Am. Med. Genet. 114(2), 150–153 (2002).
   Google Scholar
• Manor I, Tyano S, Eisenberg J, Bachner- Melman R, Kotler M, Ebstein RR The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mal PTchiatry 7 (7), 790–794 (2002) .
   Google Scholar
• Mill J, Curran S, Kent L et al. Attention deficit hyperactivity disorder (ADHD) and the dopamine D4 receptor gene, evidence of association but no linkage in a UK sample. Mal PTchiatry6(4), 440–444 (2001).
   Google Scholar
• Castellanos FX, Lau E, Tayebi N et al. Lack of association between a dopamine-4 receptor polymorphism and attention deficit hyperactivity disorder, genetic and brain morphometric analyses. Mal PTchiatr 3,431–434 (1998).
   PubMed Web of Science ®Google Scholar
• Eisenberg J, Zohar A, Mei-Tal G et al. A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD). Am. J. Med. Genet. 96 (3), 258–261 (2000).
   Google Scholar
• Hawi Z, McCarron M, Kirley A, Fitzgerald M, Gill M. No association of the dopamine DRD4 receptor with attention deficit hyperactivity disorder (ADHD) in the Irish population. Am. J. Med. Genet. 96,268-272 (2000).
   Google Scholar
• Kotler M, Manor I, Sever Y etal. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. Am. J. Med. Genet. 96(3), 278–281 (2000).
   Google Scholar
• Todd RD, Neuman RJ, Lobos EA, Jong YJ, Reich W, Heath AC. Lack of association of dopamine D4 receptor gene polymorphisms with ADHD subtypes in a population sample of twins. Am. J. Med. Genet. 105(8), 745–748 (2001).
   Google Scholar
• Mill JS, Caspi A, McClay J et al. The dopamine D4 receptor and the hyperactivity phenotype, developmental-epidemiological study. Mal PTchiatry7(4), 383–391 (2002).
   Google Scholar
• Barr CL, Feng Y, Wigg KG et al. 5'- untranslated region of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J. Med. Genet. 105(1), 84–90 (2001).
   Google Scholar
• Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the dopamine D4 7-repeat allele and attention deficit hyperactivity disorder. Am. J. Psychiatry 158(7), 1052–1057 (2001).
   Google Scholar
• Barr CL, Wigg KG, Feng Y et al. Attention- deficit hyperactivity disorder and the gene for the dopamine D5 receptor. Mal PTchiatry5, 548–551 (2000).
   PubMed Web of Science ®Google Scholar
• Payton A, Holmes J, Barrett JH et al Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder, a family-based study. Am. Med Genet. 105(5), 464–470 (2001).
   PubMed Web of Science ®Google Scholar
• Thompson M, Comings DE Mutation screening of the dopamine D1 receptor gene in Tourette's syndrome and alcohol dependent patients. Am J. Med. Genet. 81(3), 241–244 (1998).
   Google Scholar
• Barr C L, Wigg KG, Wu J et al Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder. Am. J. Med. Genet. 96,114-117 (2000).
   Google Scholar
• Muglia P, Jain U, Kennedy JL. A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in adult attention-deficit hyperactivity disorder. Behav. Brain Res. 130(1–2), 91–95 (2000).
   Google Scholar
• Comings DE, Comings BG, Muhleman D et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAIVIA 266,13,1793-1800 (1991).
   Google Scholar
• Dietz G, Comings D. A simple restriction endonuclease based test for the dopamine D2 receptor gene (DRD2) haplotypes, linkage disequilibrium of the haplotypes with the Taq Al allele. liychiatr Genet. 7(3), 133–135 (1997).
   Google Scholar
• Rowe DC, den Oil EJ, Stever C et al. The DRD2 Taq 1 polymorphism and symptoms of attention deficit hyperactivity disorder. Mal fisychiatry 4 (6), 580–586 (1999).
   Google Scholar
• Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-0-hydroxylase gene. Am. J. Med. Genet. 114(2), 154–158 (2000).
   Google Scholar
• Wigg K, Zai G, Schachar R et al. Attention deficit hyperactivity disorder and the gene for dopamine P-hydroxylase. Am. J. Psychiatry 159(6), 1046–1048 (2002).
   Google Scholar
• Smith KM, Daly M, Fischer M et al Association of the dopamine Phydroxylase gene with attention deficit hyperactivity disorder, genetic analysis of the Milwaukee longitudinal study. Am. J. Med. Genet. 119B (1), 77–85 (2003).
   Google Scholar
• Wilson MC. Coloboma mouse mutant as an animal model of hyper kinesis and attention deficit hyperactivity disorder. NeuroscL Behav. Rev 24,51–57 (2000).
   PubMed Web of Science ®Google Scholar
• Barr CL, Feng Y, Wigg K et a/. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention deficit hyperactivity disorder. Mal Psychiatry 5, 405–409 (2000).
   Google Scholar
• Kustanovich V, Merriman B, McGough J, McCracken JT, Smalley SL, Nelson SE Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. A/LI fijchiatiy8(3), 309–315 (2003).
   Google Scholar
• Brophy K, Hawi Z, Kirley A, Fitzgerald M, Gill M. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD), evidence of linkage and association in the Irish population. Mal fijchiatiy7(8), 913–917 (2002).
   Google Scholar
• Mill J, Curran S, Kent L et al Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder. Am. J. Med. Genet. 114(3), 269–271 (2002).
   Google Scholar
• Eisenberg J, Mei-Tal G, Steinberg A et al Haplotype relative risk study of catechol-o-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD), association of the high-enzyme activity Val allele with ADHD impulsive hyperactive phenotype. Am J. Med. Gene. 88(5), 497–502 (1999).
   Google Scholar
• Qian Q, Wang Y, Zhou R, Li J, Wang B, Glatt S, Faraone SV. Family-based and case-control association studies of catechol-o-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am. Med. Genet. 118B (1), 103–109 (2003).
   Google Scholar
• Barr CL, Wigg K, Malone M et al Linkage study of and attention-deficit hyperactivity disorder. Am. J. Med. Genet. 88(6), 710–713 (1999).
   Google Scholar
• Hawi Z, Millar N, Daly G, Fitzgerald M, Gill M. No association between catechol-o-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am. J. Med. Genet 96,282–284 (2000).
   Google Scholar
• Tahir E, Curran S, Yazgan Y, Ozbay F, Cirakoglu B, Asherson PJ. No association between low- and high-activity catechol-0-methyltransferase (COMT) and attention deficit hyperactivity disorder (adhd) in a sample of Turkish children. Am. J. Med. Genet. 96,285-288 (2000).
   Google Scholar
• Manor I, Kotler M, Sever Y et al Failure to replicate an association between the catechol-o-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort. Am. J. Med. Genet. 96(6), 858–860 (2000).
   Google Scholar
• Hawi Z, Foley D, Kirley A, McCarron M, Fitzgerald M, Gill M. Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD), no evidence for association in the Irish population. Mol Psychiatry6(4), 420–424 (2001).
   PubMed Web of Science ®Google Scholar
• Jiang S, Xin R, Lin S et al Linkage studies between attention-deficit hyperactivity disorder and the monoamine oxidase genes. Am. J. Med. Gene. 105(8), 783–788 (2001).
   Google Scholar
• Nebigil CG, Etienne N, Schaerlinger B, Hickel P, Launay JM, Maroteaux L. Developmentally regulated serotonin 5-HT2B receptors. Int. J. Dev. Neurosci.19(4), 365–372 (2001).
   Google Scholar
• Tang G, Ren D, Xin R, Qian Y, Wang D, Jiang S. Lack of association between the tryptophan hydroxylase gene A218C polymorphism and attention-deficit hyperactivity disorder in Chinese Han population Am. J. Med. Gene. 105(6), 485–488 (2001).
   Google Scholar
• Lucki I. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry 44(3), 151–162 (1998).
   PubMed Web of Science ®Google Scholar
• Lesch IQ, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292), 1527–1531 (1996).
   PubMed Web of Science ®Google Scholar
• Manor I, Eisenberg J, Tyano S et al Family- based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. Am. J. Med. Gene. 105(1), 91–95 (2001).
   Google Scholar
• Seeger G, Schloss P, Schmidt MET. Functional polymorphism within the promoter of the serotonin transporter gene is associated with severe hyperkinetic disorder. Mal Psychiatry 6(2), 235–238 (2001).
   PubMed Web of Science ®Google Scholar
• Kent L, Doerry U, Hardy E et al A family based assertions study of three serotonin transporter polymorphism in attention deficit hyperactivity disorder (ADHD). Mol fiychiatry7 (8), 908–912 (2002).
   Google Scholar
• Zoroglu SS, Erdal ME, Alasehirli B et al. Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder. Neuropsychobiology 45(4), 176–181 (2002).
   Google Scholar
• Brunner D, Buhot MC, Hen R, Hofer M. Anxiety, motor activation and maternal-infant interactions in 5HT13 knockout mice. Behar/. NeuroscL 113(3), 587–601 (1999).
   Google Scholar
• Hawi Z, Dring M, Kirley A et al. Serotonergic system and attention deficit hyperactivity disorder (ADHD), a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multicentre ample. Mal Ptychiatry7 (7), 718–725 (2002).
   Google Scholar
• •Emphasizes the importance of sample size and consequently the power to detect genes of minor or moderate effect.
   Google Scholar
• Quist JF, Barr CL, Schachar R et al The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Mol fiychiatry8(1), 98–102 (2003).
   Google Scholar
• Quist JF, Barr CL, Schachar R et al Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD) . Mol Ptychiatry 5 (5), 537–541 (2000).
   Google Scholar
• O'Neill ME, Hearon-Maxwell Cl, Shaw G. 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine and MK-801 but not D1 agonist C-APB. Pharm. Biochem Behav 63,237–243 (1999).
   Google Scholar
• Zoroglu SS, Erdal ME, Erdal N, Ozen S, Alasehirli B, Sivasli E. No evidence for an association between the T102c and 1438 GlA polymorphisms of the serotonin 2A receptor gene in attention deficit hyperactivity disorder in a Turkish population. Neuropsychobiology 47 (1), 17–20 (2003).
   Google Scholar
• Levitan RD, Masellis M, Basile VS et al. Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention deficit hyperactivity disorder (ADHD) in adult women with seasonal affective disorder. J. Affect. Dison171 (1–3), 229–233 (2002).
   Google Scholar
• Shih JC, Chen K, Ridd MJ. Role of MAO A and B in neurotransmitter metabolism and behaviour. PoLJ Pharmacol 51(1), 25–29 (1999).
   PubMedGoogle Scholar
• Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262, 578–580 (1993).
   Google Scholar
• Cases O, Seif, I, Grimsby J et al Aggressive behaviour and altered amounts of brain serotonin and norepinephrin in mice lacking MAOA. Science 268,1763–1766 (1995).
   PubMed Web of Science ®Google Scholar
• Jiang S, Xin R, Lin S et al Linkage studies between ADHD and the monoamine oxidasegenes.Am.j Med Genet. 105,783–788 (2001).
   PubMed Web of Science ®Google Scholar
• Jiang S, Xin R, Wu X et al. Association between attentiondeficit hyperactivity disorder and the DXS7 locus. Am. J. Med Genet. 96(3), 289–292 (2000).
   Google Scholar
• Tang G, Ren D, Xin R et al. Lack of association between the tryptophan hydroxylase gene A218C polymorphism and ADHD in Chinese Han population AinJ Med Genet. 105,485–488 (2001).
   Google Scholar
• Zimmerman H. Synatapic Bansmission, Cellular and Molecular Basis. Oxford University Press, Oxford, UK (1993).
   Google Scholar
• Aston-Jones G, Rajkowski J, Cohen J. Role of locus coeruleus in attention and behavioral flexibility. Biol. Rychiatry46, 1309–1320 (1999)
   Google Scholar
• Smith A, Nutt D. norepinephrin and attention lapses. Nature 380(6572), 291 (1996)
   PubMed Web of Science ®Google Scholar
• Amsten A. Development of the cerebral cortex, XIV. Stress impairs prefrontal cortical function. jAm. Acad. Child Adoles. Ptychiatry38, 220–222 (1999). iii Davids E, Zhang K, Kula NS, Tarazi PT, Baldessarini RJ. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J. Pharmacol Exp. Ther: 301(3), 1097–1102 (2002).
   Google Scholar
• Popper CW. Pharmacological alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Child Adolesc. Ptychiab: Gun. N Am. (3), 605–646 (2000).
   Google Scholar
• Biederman J, Spencer T Attention deficit hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol. Psychiatry 46(9), 1234–1242 (1999).
   PubMed Web of Science ®Google Scholar
• Barr CL, Kroft J, Feng Y et al. The norepinephrine transporter gene and attention-deficit hyperactivity disorder. Am. J. Med Genet. 114(3), 255–259 (2002).
   Google Scholar
• McEvoy B, Hawi Z, Fitzgerald M, Gill M. No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population. Am. J. Med Genet. 114(6), 665–666 (2002).
   Google Scholar
• Comings DE, Gad-Andavolu R, Gonzalez N et al. Additive effect of three noradrenergic genes(ADRA2A, ADRA2C, DBH) on attention deficit/hyperactivity disorder and learning disabilities in Tourette Syndrome subjects. Clin Genet. 55,160–172 (1999).
   PubMed Web of Science ®Google Scholar
• Xu C, Schachar R, Tannock R et al. Linkage study of the a2A adrenergic receptor in attention-deficit hyperactivity disorder families. Am. J. Med Genet. 105(2), 159–162 (2001).
   Google Scholar
• Barr CL, Wigg K, Zai G et al Attention-deficit hyperactivity disorder and the adrenergic receptors al C and cE2C. Mol Ptychiatry6(3), 334–337 (2001).
   Google Scholar
• Davids E, Zhang K, Tarazi Fl, Baldessarini RJ. Animal models of attention-deficit hyperactivity disorder. Brain Res. Rev 42(1), 1–21 (2003).
   Google Scholar
• Gainetdinov RR, Caron MG. An animal model of attention deficit hyperactivity disorder. Mol Med Today 6(1), 43–44 (2000).
   PubMedGoogle Scholar
• Russell VA. The nucleus accumbens motor-limbic interface of the spontaneously hypertensive as studied in vitro by the superfusion slice technique. Neurosci Biobehav. Rev 24(1), 133–136 (2000).
   Google Scholar
• Russell VA. Hypodopaminergic and hypemoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder — the spontaneously hypertensive rat. Behav Brain Res. 130(1-2), 191–196 (2002).
   Google Scholar
• Barkley RA. Attention Deficit Hyperactivity Disorder. A Handbook for Diagnosis and Treatment. Guilford, NY, USA (1990).
   Google Scholar
• Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD. Implications for research practice AND DSM-V. jAm. Acad. Child. Adolesc. Ptychiatry36,1065–1079 (1997).
   PubMed Web of Science ®Google Scholar
• Kuhne M, Schachar R, Tannack R. Impact of comorbid oppositional or conduct problems on attention deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 36,1715–1725 (1997).
   Google Scholar
• Faraone SV, Biederman J, Mennin D et al Familial subtypes of attention deficit hyperactivity disorder, a 4-year follow-up study of children from antisocial-ADHD families. J. Child Ptychol Psychiatry 39, 1045–1053 (1998).
   Google Scholar
• Thapar A, Harrington R, McGuffin P Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin study design. BE j Psychiatry 179,224–229 (2001).
   PubMed Web of Science ®Google Scholar
• Gillis JJ, Gilger JW, Penninngton BF, DeFries JC. Attention deficit disorders in reading disabled twins, evidence for a genetic etiology. J. Abn. Child. Ptychol 20, 303–315 (1992).
   PubMed Web of Science ®Google Scholar
• Curran S, Mill J, Sham P etal. QTL Association analysis of the DRD4 exon 3 VNTR polymorphism in a population sample of children screened with a parent rating scale for ADHD symptoms. Am. J. Med Genet. 105, 387–393 (2001).
   Google Scholar
• Winsberg BG, Comings DE. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. Am. Acad. Child Adolesc. Psychian y38 (12), 1474–1477 (1999).
   Google Scholar
• Roman T, Szobot C, Martins S, Biederman J, Rohde LA, Hutz M. Dopamine transporter gene and response to methylphenidate in attention deficit hyperactivity disorder. Phatmacogenetics12, 497–499 (2002).
   PubMedGoogle Scholar
• Kirley A, Lowe N, Hawi Z et al Association of the 480bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. (2003) (In Press).
   Google Scholar
• Doucette-Stamm LA, Blakely DJ, Tian J, Mockus S, Mao JI. Population genetic study of the human dopamine transporter gene (DAT1). Genet. Epidemiol 12, 303–308 (1995).
   Google Scholar
• Hawi Z, Lowe N, Kirley A et al. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. MoL Psychiatry 8(3), 299–308 (2003) .
   Google Scholar
• Miller GM, Madras BK. Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mal Psychiatry 7, 44–55 (2000).
   Web of Science ®Google Scholar
• Daly MJ, Rioux JD, Schaffner SF et al. High resolution haplotype structure in the human genome. Nat. Genet. 29, 229–232 (2001).
   PubMed Web of Science ®Google Scholar
• Johnson GC, Esposito L, Barratt L et al. Haplotype tagging for tht identification of common disease gene. Nat. Genet. 29, 233–237 (2001).
   PubMed Web of Science ®Google Scholar
• Rioux JD, Daly MJ, Silverberg Ma et al Genetic variation in the 5q31 cytokine gene cluster onfers susceptibility to Crohn disease. Nat. Genet. 29(2), 223–228 (2001). Affiliations
   Google Scholar